PAI
IMDZ

ProQuest Associates IV’s Immune Design Corp. IMDZ Stock Holding History

ProQuest Associates IV’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$4.27M Hold
1,236,394
– – 8.06% 3
2018
Q2 		$5.63M Hold
1,236,394
– – 8.66% 3
2018
Q1 		$4.08M Hold
1,236,394
– – 4.69% 4
2017
Q4 		$4.82M Sell
1,236,394
-176,886
-13% -$963K 6.4% 4
2017
Q3 		$14.6M Sell
1,413,280
-549,440
-28% -$5.41M 14.65% 4
2017
Q2 		$19.1M Hold
1,962,720
– – 24.47% 2
2017
Q1 		$13.3M Hold
1,962,720
– – 4.01% 3
2016
Q4 		$10.8M Hold
1,962,720
– – 3.06% 3
2016
Q3 		$14.9M Hold
1,962,720
– – 4.1% 3
2016
Q2 		$16M Hold
1,962,720
– – 6.51% 3
2016
Q1 		$25.5M Hold
1,962,720
– – 9.91% 3
2015
Q4 		$39.4M Hold
1,962,720
– – 7.61% 3
2015
Q3 		$23.9M Sell
1,962,720
-21,138
-1% -$396K 5.67% 3
2015
Q2 		$41M Sell
1,983,858
-430,182
-18% -$10.2M 8.41% 2
2015
Q1 		$51M Sell
2,414,040
-281,717
-10% -$7.35M 16.62% 2
2014
Q4 		$83M Buy
+2,695,757
New +$74.9M 42.05% 1

Other funds holding IMDZ

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ProQuest Associates IV's IMDZ Position: Q3 2018 in Review

ProQuest Associates IV held its Immune Design Corp. (IMDZ) position steady in Q3 2018 at 1,236,394 shares worth $4.27M. The position accounts for 8.06% of the portfolio, ranked #3.

ProQuest Associates IV first reported a position in IMDZ in Q4 2014 and has held it in 16 quarters since. The position peaked at $83M in Q4 2014. 71 funds tracked by Wall St. Rank hold IMDZ as of Q3 2018.

  • ProQuest Associates IV held 1,236,394 shares of Immune Design Corp. worth $4.27M as of Q3 2018.
  • ProQuest Associates IV left its Immune Design Corp. share count unchanged in Q3 2018.
  • Immune Design Corp. made up 8.06% of ProQuest Associates IV's portfolio in Q3 2018, its #3 holding.
  • ProQuest Associates IV first reported a position in Immune Design Corp. in Q4 2014 and has held it in 16 quarters since.
  • ProQuest Associates IV's Immune Design Corp. position peaked at $83M in Q4 2014.
  • 71 funds tracked by Wall St. Rank held Immune Design Corp. as of Q3 2018.

Based on ProQuest Associates IV's 13F filing for Q3 2018, filed 14 Nov 2018.